FDA Drug Application (020873) for ANGIOMAX by THE MEDICINES CO

Back to FDA Applications sponsored by THE MEDICINES CO

Application Number020873
Product Number001
FormINJECTABLE;INTRAVENOUS
Dosage250MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameANGIOMAX
Active IngredientBIVALIRUDIN

Active IngredientCount
List of drugs with Active Ingredient BIVALIRUDIN2


Back to FDA Applications sponsored by THE MEDICINES CO